|
PatentVote.com: Vote on your favourite invention!
|
|
 |
Title: Polymeric orthoesters housing beneficial drug for controlled release therefrom
Claims: I claim: 1. A composition of matter comprising an orthoester polymer of the formula: ##STR40## wherein R.sub.1 is a member selected from the group consisting of hydrogen, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 atoms, cycloalkyl of 3 to 8 carbon atoms, cycloalkyl of 3 to 8 carbons substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms and alkoxy of 1 to 20 carbon atoms, cycloalkenyl of 4 to 8 carbon atoms, and cycloalkenyl of 4 to 8 carbon atoms substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms and alkoxy of 1 to 20 carbon atoms; and R.sub.2 is a member selected from the group consisting of alkylene of 1 to 20 carbon atoms, alkenylene of 2 to 20 carbon atoms, cycloalkylene of 3 to 8 carbon atoms, cycloalkylene of 3 to 8 carbon atoms substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms and alkoxy of 1 to 20 carbon atoms; cycloalkylene of 4 to 8 carbon atoms, and cycloalkenylene of 4 to 8 carbon atoms substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms and alkoxy of 1 to 20 carbon atoms; a is 2 to 3, n is greater than 10, and about 0.01% to about 40% by weight of a beneficial drug dispersed in said polymer, and wherein said drug is released at a controlled and continuous rate to the environment of use as said polymer erodes over a prolonged period of time. 2. The composition of matter comprising the orthoester polymer and the beneficial drug according to claim 1 wherein the drug is selected from the group consisting of analgesics, antipyretics, anti-inflammatory, hormonal, sympathomimetic, diuretic and ophthalmic drugs. 3. The composition of matter comprising the orthoester polymer and the beneficial drug according to claim 1 wherein the drug is a member selected from the group consisting of progestational and estrogenic steroids. 4. The composition of matter comprising the orthoester polymer and the beneficial drug according to claim 1, wherein the drug is an ophthalmic drug selected from the group consisting of pilocarpine or its therapeutically acceptable salts, eserine salicylate, atropine, homatropine and eucatropine. 5. The composition of matter comprising the orthoester polymer and the beneficial drug according to claim 1 wherein the beneficial drug is a sympathomimetic drug selected from the group consisting of epinephrine, amphetamine, ephedrine and norepinephrine. 6. The composition of matter comprising the orthoester polymer and the beneficial drug according to claim 1 wherein the beneficial drug is a local anesthetic selected from the group consisting of procaine, lidocaine, naepaine, piperocaine, tetracaine, and dibucaine. 7. The composition of matter according to claim 1, wherein R.sub.1 is a cycloalkyl of 3 to 8 carbon atoms substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms, and alkoxy of 1 to 20 carbon atoms. 8. The composition of matter according to claim 1, wherein R.sub.1 is a cycloalkenyl of 4 to 8 carbon atoms substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms, and alkoxy of 1 to 20 carbon atoms. 9. The composition of matter according to claim 1 wherein R.sub.2 is a cycloalkylene of 3 to 8 carbon atoms substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms and alkoxy of 1 to 20 carbon atoms. 10. The composition of matter according to claim 1 wherein R.sub.2 is a cycloalkenylene of 4 to 8 carbon atoms substituted with a member selected from the group consisting of alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 20 carbon atoms and alkoxy of 1 to 20 carbon atoms. Other info: Inventors: Capozza, Richard C. (Palo Alto, CA, US) Application Number: 675185 Filing Date: 1976-04-08 Publication_date: 1978-01-03 Assignee: Alza Corporation (Palo Alto, CA) Primary Class(es): 514/166 514/161, 514/304, 514/312, 514/317, 514/327, 514/397, 514/535, 514/619, 514/626, 514/653, 514/654, 528/271, 528/403, 528/405, 528/425 Other Classes: US Patent Ref:
Other Refs: Primary Examiner: Schenkman, Leonard Assistant Examiner: Attorney: Sabatine; Paul L., Ciotti; Thomas E., Mandell; Edward L. |
|